Teva Pharma Names Krinsky Chairman - Teva Pharmaceutical Indus (NYSE:TEVA)

27% profits every 20 days?

This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) announced today theappointment of Professor Itzhak Krinsky as Chairman of Teva Japan and TevaSouth Korea and Head of Business Development Asia-Pacific. Currently servingas Executive Vice President, Corporate Business Development at Teva, ProfessorKrinsky's new appointment will be effective mid-October. Professor Krinskywill be responsible for overseeing Teva's generic and branded pharmaceuticalsbusinesses in Japan and South Korea. Additionally, Professor Krinsky willmanage Business Development for the Asia-Pacific region. He will continue toserve as a member of the Teva Executive Committee and will be located inTokyo.

27% profits every 20 days?

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!